Mechanical Ventilators Market Size & Share 2025 - 2034

Mechanical Ventilators Market Size

The global mechanical ventilators market was valued at USD 2.8 billion in 2024. The market is expected to reach from USD 2.9 billion in 2025 to USD 6 billion in 2034, growing at a CAGR of 8.6% during the forecast period, according to the latest report published by Global Market Insights Inc. Increased incidence of respiratory ailments, soaring ICU admissions, technological innovation, and rising demand for critical care facilities are major factors driving market growth.

Mechanical ventilators market provides innovative healthcare solutions to providers, life sciences companies, and healthcare technology organizations, improving regulation compliance, patient performance, and operational effectiveness. Products and solutions range from invasive and non-invasive ventilators, critical care and portable systems to digital respiratory monitoring devices that provide effective respiratory assistance, disease control, and enhanced quality of life.
 

Some of the major players in the market are Getinge, Hamilton Medical, Dräger, Philips, and Medtronic. These players maintain their competitive advantage through ongoing product innovation, extensive global reach, strategic alliances, and large investments in research and development to address increasing clinical requirements and broaden their market presence.
 

The market has decreased from USD 5.2 billion in 2021 to USD 3.1 billion in 2023. One of the primary reason is due to the waning impact of the COVID-19 pandemic, which had previously driven an unprecedented surge in demand. As infection rates declined and emergency procurement slowed, sales volumes normalized. Additionally, excess inventory stocked during the pandemic, reduced ICU admissions for COVID-related respiratory cases, and the shift toward more routine healthcare needs contributed to the market’s contraction during this period.
 

The global mechanical ventilators market is driven by several key factors that highlight its vital role in modern healthcare. Rising prevalence of chronic respiratory diseases such as COPD, asthma, and sleep apnea is creating sustained demand for ventilatory support systems. Growing ICU admissions, driven by aging populations and the increasing burden of critical illnesses, further boost market growth. Technological advancements, including the integration of artificial intelligence, digital respiratory monitoring, and advanced patient-ventilator interfaces, are improving treatment precision, patient comfort, and outcomes. The demand for portable and home healthcare ventilators is expanding as healthcare systems emphasize patient-centric care and cost efficiency.
 

Moreover, the rising investment in healthcare infrastructure, particularly in emerging economies, supports greater adoption of mechanical ventilators in both hospital and ambulatory surgical centers. Increasing awareness regarding early intervention in respiratory conditions, coupled with strategic collaborations and innovations from leading players, strengthens market expansion and ensures that ventilators remain essential tools in critical and long-term care.
 

Mechanical ventilators are life-support devices designed to assist or replace spontaneous breathing in patients with respiratory failure or compromised lung function. They deliver controlled oxygen and airflow through invasive or non-invasive methods, ensuring adequate gas exchange, stabilizing critical conditions, and improving patient outcomes in intensive care and homecare settings.
 

Mechanical Ventilators Market Trends

The growing incidence of chronic respiratory illnesses, including chronic obstructive pulmonary disease (COPD), asthma, pulmonary fibrosis, and sleep apnea, is a key growth driver of the market.
 

• Worldwide, the increasing prevalence of respiratory diseases, propelled by demographic aging, urbanization, air pollution, and changes in lifestyle, has driven the need for improved respiratory support systems. Macro-economically, the health systems globally are facing increasing pressures to deliver cutting-edge critical care services, leading to higher investments in ICU facilities, hospital development, and ventilator acquisitions.
   
• This trend is especially significant in developing economies as government healthcare programs and insurance coverage enhance access to medical devices. Microeconomically, hospitals, clinics, and homecare services are increasingly using mechanical ventilators to provide timely intervention, lower patient mortality, and maximize the utilization of resources.
   
• Technological advancements have further amplified this demand, with modern ventilators incorporating AI-powered monitoring, adaptive ventilation modes, portable designs, and digital interfaces that enhance patient comfort and clinical efficiency.
   
• Innovations such as non-invasive ventilation, remote monitoring, and integration with electronic health records enable precise respiratory management, reducing complications and improving outcomes.
   
• Furthermore, ongoing research and development by leading players in the market, including Getinge, Hamilton Medical, and Philips, is driving product differentiation and expanding the applicability of ventilators beyond intensive care units to homecare settings.  
   

Mechanical Ventilators Market Analysis

Based on the product type, the mechanical ventilators market is bifurcated into intensive care ventilators, and portable ventilators. The intensive care ventilators segment is further divided into high-end, mid-end, and basic-end. The intensive care ventilators segment has asserted its dominance in the market by securing a significant market share of 83.2% in 2024, driven by rising prevalence of severe respiratory illnesses and increasing ICU admissions drive demand for advanced intensive care ventilators. The segment is expected to exceed USD 4.8 billion by 2034, growing at a CAGR of 8.3% during the forecast period.
 

On the other hand, the portable ventilators segment is expected to grow with a CAGR of 10%. The growth of this segment can be attributed to the growing need for home-based and emergency respiratory support fuels adoption of portable ventilators.
 

• The market segment is led by growing incidence of severe respiratory conditions such as acute respiratory distress syndrome (ARDS), chronic obstructive pulmonary disease (COPD), pneumonia, and complications due to COVID-19. Rising ICU admissions worldwide, especially among elderly populations and comorbid patients, have accelerated the need for high-performance, advanced ventilators that provide accurate and consistent respiratory care.
   
• High-end and mid-end ventilators are being invested in by hospitals and critical care centers to optimize clinical workflow, decrease mortality, and improve patient outcomes. Technological developments, including AI-driven ventilation, adaptive ventilation modes, and real-time monitoring, further boost the segment's growth by enhancing patient safety, decreasing ventilator-associated complications, and enabling personalized care.
   
• Moreover, government-led efforts and investments in healthcare infrastructure, particularly in developing economies, are increasing ICU bed capacities and pushing ventilator adoption.
   
• The portable ventilators segment held a revenue of USD 472.4 million in 2024, with projections indicating a steady expansion at 10% CAGR from 2025 to 2034. The segment is witnessing rapid growth due to the increasing demand for home-based respiratory care and emergency medical support. Rising prevalence of chronic respiratory diseases, including COPD, neuromuscular disorders, and sleep apnea, has prompted patients and caregivers to adopt portable solutions for long-term ventilation outside hospital settings.
   
• Emergency medical services, ambulatory care, and disaster preparedness initiatives are also fueling the need for lightweight, easy-to-transport ventilators that provide reliable respiratory support in critical situations. Technological innovations, including battery-operated systems, compact designs, non-invasive ventilation modes, and integrated monitoring features, enhance usability, patient comfort, and clinical efficiency.
   
• Furthermore, telemedicine integration and remote monitoring capabilities enable healthcare providers to track patient conditions and adjust therapy in real time, increasing adoption rates.
   

Based on interface, the mechanical ventilators market is bifurcated into invasive ventilation, and non-invasive ventilation. The invasive ventilation segment dominated the market with a revenue share of 77.5% in 2024 and is expected to reach USD 4.5 billion within the forecast period.
 

• The segment leads because it plays a vital role in treating patients with extreme respiratory failure and potentially life-threatening complications. Increased incidence of chronic and acute respiratory ailments, such as COPD, ARDS, pneumonia, and post-surgical respiratory complications, strongly drives the market for invasive ventilators. Increased ICU beds and intensive care facilities globally also drive adoption, providing access to ventilatory support during emergencies.
   
• Technological developments, including more effective patient-ventilator interfaces, adaptive ventilation modes, and compatibility with digital monitoring systems, improve patient outcomes and clinical effectiveness, rendering invasive ventilators an essential element in critical care.
   
• Tertiary care facilities and hospitals give preference to invasive ventilators for complicated cases because of their accuracy, safety, and potential for handling extended respiratory assistance.
   
• The non-invasive ventilation segment held a revenue of USD 633.4 million in 2024, with projections indicating a steady expansion at 9.8% CAGR from 2025 to 2034. The segment is driven by increasing demand for patient-friendly, less invasive respiratory support alternatives. NIV is widely used for managing chronic respiratory conditions, sleep apnea, and moderate respiratory distress, reducing the need for intubation and associated complications.
   
• The growing preference for homecare and outpatient treatment further fuels the adoption of non-invasive ventilators, as they provide mobility, comfort, and ease of use for patients requiring long-term respiratory support.  
   

Based on ventilator type, the mechanical ventilators market is classified into adult ventilators, and neonatal ventilators. The adult ventilators segment dominated the market with a revenue share of 91.2% in 2024 and is expected to reach USD 5.6 billion within the forecast period.
 

• The segment of adult ventilators has the largest market share because of the vast prevalence of chronic and acute respiratory diseases in adults, such as COPD, asthma, pneumonia, and respiratory failure due to COVID-19. Growing admissions to the ICU and the rising rates of multi-organ critical illness among the elderly further increased demand for sophisticated adult ventilators.
   
• Technological advancements, including AI-enabled ventilation, adaptive support modes, and enhanced patient-ventilator interfaces, increase clinical efficiency, patient comfort, and safety, which prompts the hospitals to implement latest devices.
   
• Further, the increasing trend towards portable and non-invasive ventilators for homecare purposes also fuels growth, providing constant respiratory support outside the hospital environment.
   
• The neonatal ventilators segment held a revenue of USD 245.8 million in 2024, with projections indicating a steady expansion at 6% CAGR from 2025 to 2034. The neonatal ventilators segment is driven by the increasing prevalence of preterm births, low birth weight, and respiratory distress syndrome (RDS) in newborns globally.
   
• Technological advancements, including high-frequency oscillatory ventilation, non-invasive neonatal ventilators, and integration with digital monitoring systems, allow clinicians to tailor respiratory support for fragile infants, improving survival rates and long-term health outcomes.
   

Based on application, the mechanical ventilators market is classified into resuscitation, emergency/transport, anesthesiology, clinical applications, homecare applications, sleep apnea therapy, and other applications. The resuscitation segment dominated the market with a revenue share of 48.1% in 2024 and is expected to reach USD 2.9 billion within the forecast period.
 

• The resuscitation portion prevails with the urgent requirement for prompt respiratory assistance during life-threatening situations like cardiac arrest, respiratory failure, and critical trauma. Advanced resuscitation ventilators are largely dependent on hospitals and emergency care units for prompt interventions, oxygenating, and stabilizing patients in delicate moments.
   
• Macro drivers for this segment are rising incidence of cardiovascular diseases, growing hospitalization rates, and the acceleration in government efforts to enhance emergency care infrastructure.
   
• Microeconomic factors entail hospitals and emergency care services investing in performance resuscitation devices to improve survival rates of patients and minimize ICU burden.
   
• The emergency/transport segment held a revenue of USD 568.3 million in 2024, with projections indicating a steady expansion at 9.2% CAGR from 2025 to 2034.
   
• The transport and emergency ventilators segment is fueled by the expanding need for quick, mobile respiratory care in pre-hospital environments, ambulances, and patient transfer situations. Growing road accidents, trauma, and acute respiratory emergencies require dependable, portable ventilators that maintain patient stability during transportation.
   
• Technological advancements, including smaller sizes, automated ventilation modes, real-time monitoring, and integration with mobile healthcare systems, improve operational efficiency as well as patient safety. In addition, integration with telemedicine facilitates remote guidance during transportation, further boosting adoption.
   
• The anesthesiology segment held a revenue of USD 308.7 million in 2024, with projections indicating a steady expansion at 7.6% CAGR from 2025 to 2034.
   
• The anesthesiology segment of the mechanical ventilators market is propelled by the growing volume of surgical procedures worldwide, which require precise ventilation management during anesthesia. Rising elective and emergency surgeries, particularly in aging populations and countries with expanding healthcare infrastructure, create significant demand for advanced anesthesiology ventilators.
   

Based on mode, the mechanical ventilators market is classified into pressure mode ventilator, control mode ventilator, and combined mode ventilator. The pressure mode ventilator segment dominated the market with a revenue share of 49.9% in 2024 and is expected to reach USD 2.9 billion within the forecast period.
 

• The pressure mode ventilator market leads as it provides increased safety, patient comfort, and versatility for various respiratory conditions. The ventilators provide a constant airway pressure, reducing lung injury while effectively ventilating patients with impaired lung compliance, and thus being extremely appropriate for critical care environments.
   
• Increased incidence of chronic respiratory illness, including COPD and ARDS, fuels demand for accurate pressure-controlled ventilation to minimize complications. Technology innovations in the form of intelligent sensors, auto-pressure adaptation, and AI-based monitoring enhance clinical productivity and patient outcome.
   
• Furthermore, the market also enjoys growing ICU admissions and capacity expansion for critical care worldwide. Pressure mode ventilators are preferred by homecare providers and hospitals due to their capacity to fit the unique needs of patients, improve gas exchange, and minimize ventilator-associated complications.
   
• The control mode ventilator segment held a revenue of USD 938.6 million in 2024, with projections indicating a steady expansion at 8.9% CAGR from 2025 to 2034. The control mode ventilator segment is driven by its precise, consistent ventilation delivery, making it essential for patients with severe respiratory failure or under anesthesia.
   
• These ventilators allow clinicians to set fixed tidal volumes or flow rates, ensuring predictable oxygenation and ventilation, particularly in critical care and surgical settings. Rising ICU admissions, postoperative respiratory complications, and the growing burden of acute respiratory conditions increase demand for reliable control mode ventilators.
   

Based on end use, the mechanical ventilators market is classified into hospitals, ambulatory surgical centers, homecare, and other end users. The hospitals segment dominated the market with a revenue share of 61.7% in 2024 and is expected to reach USD 3.7 billion within the forecast period.
 

• The two largest segments account for over 87.8% of the total market value. The hospitals segment dominates the mechanical ventilators market due to its pivotal role in managing critically ill patients and supporting intensive care units (ICUs). Rising hospital admissions for respiratory conditions, including COPD, pneumonia, and COVID-19-related complications, drive consistent ventilator demand.
   
• The increasing number of ICU beds and expansion of tertiary care facilities globally further bolster market growth. Hospitals are investing heavily in advanced ventilator technologies, such as AI-assisted monitoring, adaptive ventilation modes, and integrated digital platforms, to enhance patient outcomes and operational efficiency.
   
• Additionally, stringent regulatory standards and a growing emphasis on patient safety and clinical quality necessitate reliable ventilatory support systems.
   
• Leading players, including Getinge, Hamilton Medical, and Philips, continuously innovate to meet hospitals’ evolving clinical needs, ensuring high adoption rates in this segment.
   
• The ambulatory surgical centers segment held a revenue of USD 734.6 million in 2024, with projections indicating a steady expansion at 8.8% CAGR from 2025 to 2034. Ambulatory surgical centers (ASCs) are witnessing increasing adoption of mechanical ventilators due to the growing trend of outpatient surgeries and minimally invasive procedures. As surgical volumes rise, ASCs require reliable ventilation solutions to manage anesthesia and ensure patient safety during procedures.
   
• Technological advancements, such as compact and portable ventilators with intuitive interfaces, allow ASCs to provide critical respiratory support without the infrastructure demands of traditional hospitals.
   

North America Mechanical Ventilators Market

North America dominated the global market with the highest market share of 36.7% in 2024.
 

• North America dominates the market for mechanical ventilators worldwide, powered by the established healthcare infrastructure in the region, high spending on healthcare, and sophisticated critical care facilities. Increasing incidence of respiratory illnesses, such as COPD, asthma, and acute respiratory distress syndrome (ARDS), coupled with population aging, has boosted the requirement for ventilatory care in hospitals and homecare settings.
   
• Technological innovations, such as AI-based monitoring, transportable ventilators, and non-invasive devices, have added further impetus to market growth through enhancing patient outcomes and operating efficiency.
   
• The availability of the major players like Getinge, Hamilton Medical, Dräger, Philips, and Medtronic, who invest heavily in research and development, guarantees product innovation and availability. 
   

The U.S. mechanical ventilators market was valued at USD 1.9 billion and USD 1.3 billion in 2021 and 2022, respectively. In 2024, the market size decreased to USD 1 billion from USD 1.1 billion in 2023.
 

• The U.S. is the largest contributor to the North American market, driven by a combination of high disease prevalence, robust healthcare infrastructure, and advanced technological adoption. Increasing cases of chronic respiratory diseases, such as COPD, sleep apnea, and ARDS, have escalated the demand for mechanical ventilators in hospitals, homecare, and ambulatory surgical centers.
   
• Significant investments in healthcare, coupled with government initiatives like Medicare and Medicaid coverage, facilitate widespread ventilator deployment. The COVID-19 pandemic highlighted critical care deficiencies, prompting hospitals to expand ICU capacity and upgrade to next-generation ventilators.
   
• Technological innovations, including AI-assisted ventilation, portable devices, and telemonitoring systems, enhance clinical efficiency, patient safety, and real-time monitoring, encouraging adoption.
   

Europe Mechanical Ventilators Market

Europe mechanical ventilators market accounted for USD 889.5 million in 2024 and is anticipated to show lucrative growth over the forecast period.
 

• The European market is spurred by growing incidences of respiratory diseases, aging populations, and demand for sophisticated critical care facilities. High rates of COPD, asthma, and other pulmonary conditions in European nations drive the demand for ventilatory care in hospitals, home care, and ambulatory care.
   
• Technological developments, including AI-powered ventilators, remote monitoring, and mobile devices, are also facilitating market growth by improving patient safety, clinical efficacy, and convenience.
   
• Increased healthcare spending, government efforts to modernize hospital infrastructure, and favorable reimbursement policies are macro-level drivers that promote widespread use of mechanical ventilators.
   
• Microeconomic considerations, including hospital expansions, increased ICU admissions, and healthcare providers' emphasis on enhancing patient outcomes, also contribute significantly.
   

Germany dominates the European mechanical ventilators market, showcasing strong growth potential.
 

• Germany’s market is primarily driven by a growing burden of respiratory diseases, an aging population, and a well-established healthcare system with advanced critical care facilities. High incidences of COPD, pulmonary infections, and post-surgical respiratory complications increase the demand for reliable and technologically advanced ventilators in hospitals, ICUs, and homecare settings.
   
• Germany’s strong focus on research and development encourages continuous product innovation by market leaders, including Getinge, Dräger, and Hamilton Medical.
   

Asia Pacific Mechanical Ventilators Market

The Asia Pacific market is anticipated to grow at the highest CAGR of 11.2% during the analysis timeframe.
 

• Asia Pacific mechanical ventilators market is anticipated to be the highest-growing market in the world, propelled by several macro and microeconomic drivers. The increase in prevalence of chronic respiratory ailments, such as COPD, asthma, and pneumonia, especially in populous nations like India and Indonesia, is boosting ventilator demand.
   
• Public healthcare spending and investment by government in critical care facilities, including ICU upgrades and hospital modernization initiatives, are enhancing the region's capability to embrace sophisticated ventilators.
   
• Technological innovations, such as portable and non-invasive ventilators, AI-enabled integration, and digitalized monitoring solutions, are further enhancing adoption in hospitals and homecare environments.
   
• Urbanization, increased income levels, and widening health insurance coverage are boosting access to advanced levels of healthcare services, driving the Asia Pacific market collectively towards rapid growth and providing enormous opportunities for ventilator manufacturers globally.
   

China mechanical ventilators market is estimated to grow with a significant CAGR, in the Asia Pacific market.
 

• The country’s large population and rising prevalence of chronic respiratory conditions, such as COPD, pulmonary fibrosis, and pneumonia, create sustained demand for both invasive and non-invasive ventilators. Government programs focused on modernizing hospitals, expanding ICU capacity, and promoting advanced medical technologies are providing strong macroeconomic support.
   
• On a microeconomic level, Chinese hospitals and homecare providers are increasingly investing in high-precision ventilators equipped with AI-assisted monitoring, adaptive ventilation modes, and remote connectivity, improving patient outcomes and operational efficiency.
   
• Strategic partnerships, local manufacturing, and research and development initiatives by leading players enhance product accessibility and affordability, further boosting market adoption. Collectively, these factors position China as a key growth market within the Asia Pacific mechanical ventilators landscape.
   

Latin American Mechanical Ventilators Market

Brazil leads the Latin American market, exhibiting remarkable growth during the analysis period.
 

• The country faces a growing burden of chronic respiratory conditions, including COPD, asthma, and pneumonia, which fuels consistent ventilator demand across hospitals and homecare settings. Additionally, the COVID-19 pandemic highlighted gaps in ICU capacity, prompting long-term investments in modern ventilators and critical care technologies.
   
• Macro-level factors, such as rising healthcare expenditure, government healthcare initiatives, and supportive reimbursement policies, further encourage ventilator adoption.
   
• On a microeconomic level, hospitals, ambulatory surgical centers, and private clinics are expanding ICU beds and acquiring advanced ventilators to enhance patient outcomes.
   
• Technological advancements, including portable and non-invasive ventilators, AI-enabled monitoring, and integration with digital health platforms, are also increasing clinical efficiency.      
   

Middle East and Africa Mechanical Ventilators Market

Saudi Arabia market to experience substantial growth in the Middle East and Africa market in 2024.
 

• The mechanical ventilators market in Saudi Arabia is witnessing rapid growth due to rising respiratory illnesses, increasing ICU capacity, and strategic government healthcare initiatives. The prevalence of chronic respiratory diseases, including asthma, COPD, and occupational lung conditions, is driving demand for advanced ventilatory support across hospitals and specialized care centers.
   
• Macro-level drivers include significant government investments under the Saudi Vision 2030 healthcare reforms, which prioritize modernizing hospital infrastructure, expanding critical care services, and improving patient access to life-saving medical devices.
   
• Microeconomic factors, such as increasing hospital admissions, the adoption of minimally invasive surgeries, and the expansion of private healthcare networks, further propel ventilator demand.
   
• Technological advancements, including AI-integrated ventilators, remote monitoring capabilities, and portable systems for homecare, enhance operational efficiency and patient safety.
   

Mechanical Ventilators Market Share

The market is highly competitive, with leading medical device companies focusing on continuous product innovation, technological advancements, and strategic partnerships to consolidate their market positions. Rising prevalence of chronic respiratory diseases, increasing ICU admissions, and growing adoption of non-invasive and homecare ventilation solutions are driving companies to leverage research and development investments, AI integration, and connected respiratory monitoring systems to improve patient outcomes and operational efficiency. The shift toward value-based and home-based healthcare is encouraging players to develop cost-effective, patient-centric ventilators and expand their presence in emerging markets.
 

Key players include Getinge, Hamilton Medical, Dräger, Philips, and Medtronic, collectively accounting for 41.5% of the global market. These companies maintain leadership through diverse ventilator portfolios, strong global distribution networks, and continuous innovations in invasive and non-invasive ventilators, portable systems, and digital respiratory monitoring technologies. Their dominance is reinforced by strategic collaborations with hospitals, ambulatory centers, and homecare providers to enhance adoption and accessibility.
 

Smaller and niche players are gaining traction by offering portable, user-friendly, and specialized ventilators. Competitive differentiation increasingly depends on delivering technologically advanced, AI-integrated, and cost-efficient ventilators tailored to critical care, perioperative, and homecare settings. As the market evolves, competition is expected to intensify, with both established leaders and emerging firms pursuing innovation, digital integration, and strategic alliances to capture greater market share.
 

Mechanical Ventilators Market Companies

Few of the prominent players operating in the mechanical ventilators industry include:

• ACOMA Medical
• Aeonmed
• Air Liquide Medical Systems
• Allied Medical
• Baxter
• Bio-Med Devices
• Breas Medical
• Carl Reiner
• Dräger
• Foremost Meditech
• Fisher & Paykel
• GE Healthcare
• Getinge
• Hamilton Medical
• ICU Medical
• Medtronic
• Mindray
• Nihon Kohden
• Noccarc Robotics
• Philips
• ResMed
• Skanray Technologies
• ZOLL Medical
   
• Getinge

Getinge leads the mechanical ventilators market with a share of 11.5% in 2024. Getinge’s differentiates itself through its comprehensive critical care portfolio, combining advanced mechanical ventilators with integrated ICU solutions. Its focus on innovation, reliability, and patient safety, supported by a robust global distribution network and continuous research and development investments, enables hospitals and homecare providers to deliver efficient, high-quality respiratory care.
 

• Hamilton Medical

Hamilton Medical specializes in intelligent ventilation solutions that emphasize automation, adaptive modes, and AI-enabled monitoring. Its ventilators are designed for precision, patient comfort, and clinical efficiency, making them highly suitable for critical care and homecare settings. Continuous innovation and strong training support differentiate Hamilton in the global ventilators market.
 

Mechanical Ventilators Industry News:

• In January 2024, Koninklijke Philips N.V. announced discontinuation of select U.S. respiratory products, including ventilators, SimplyGo Mini, SimplyGo, and Everflo oxygen concentrators. This withdrawal is expected to significantly impact the ventilators market, with approximately 70% of respondents in a February 2024 HME News survey predicting notable industry shifts.
   
• In May 2023, Air Liquide Medical Systems launched the ALNEST N1 Silent nasal mask, designed for home non-invasive ventilation, particularly for CPAP-treated Sleep Apnea patients. This addition strengthened the company’s medical device portfolio, enhanced its market reputation, and expanded offerings for homecare respiratory support, addressing patient comfort and compliance needs.
   
• In May 2023, Fisher & Paykel Healthcare Corporation Limited introduced the Airvo 3 high flow system, featuring targeted oxygen delivery, integrated battery, user-friendly interface, pediatric and neonatal settings, and increased maximum flow rate. This strategic launch expanded the company’s customer base, strengthened its competitive position, and enhanced its product portfolio in high-flow respiratory therapy.
   
• In January 2023, Getinge launched its Servo-c mechanical ventilator, offering lung-protective therapy for pediatric and adult patients. Featuring modular components for intelligent fleet management, CO2 monitoring, and Servo Compass technology, it ensures optimal uptime, reduces costs, and eliminates dependency on proprietary disposables.
   
• In October 2022, Medtronic decided to separate its respiratory interventions (PMRI) and patient monitoring businesses from the ventilator market. The decision followed rapid expansion during the COVID-19 pandemic, which caused ventilator shortages, allowing the company to focus on core operations while enabling other players to capture ventilator market opportunities.
   

The mechanical ventilators market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million from 2021 - 2034 for the following segments:

Click here to Buy Section of this Report

Market, By Product

• Intensive care ventilators
  • High-end
  • Mid-end
  • Basic-end
• Portable ventilators

Market, By Interface

• Invasive ventilation
• Non-invasive ventilation
  • CPAP
  • BiPAP
  • APAP
  • Other non-invasive ventilation

Market, By Ventilator Type

• Adult ventilators
• Neonatal ventilators

Market, By Application

• Resuscitation
• Emergency/Transport
• Anesthesiology
• Clinical applications
• Homecare applications
• Sleep apnea therapy
• Other applications

Market, By Mode

• Pressure mode ventilator
• Control mode ventilator
• Combined mode ventilator

Market, By End Use

• Hospitals
• Ambulatory surgical centers
• Homecare
• Other end use

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE